CollPlant Biotechnologies (CLGN) Net Income (2017 - 2026)
CollPlant Biotechnologies' Net Income came in at -$2.73 million for the quarter ended Jun 30, 2026, compared with -$3.35 million a year earlier.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Net Income (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, CollPlant Biotechnologies reported Net Income of -$12.53 million; for the year ended Dec 31, 2025, it came in at -$11.49 million.
- Going back by year, Net Income was -$16.61 million in the year ended Dec 31, 2024, -$7.02 million in the year ended Dec 31, 2023, -$16.93 million in the year ended Dec 31, 2022 and $237,000 in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Net Income since the quarter ended Mar 30, 2025.
- Business Quant data shows CLGN's Net Income at -$3.12 million (quarter ended Mar 30, 2026), -$3.21 million (quarter ended Dec 31, 2025) and -$3.48 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | CollPlant Biotechnologies | 4.98 Mn | -17.38 Mn | -456,000.00 | -2.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.73 Mn |
| Mar 31, 2026 | -3.10 Mn |
| Dec 31, 2025 | -3.21 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Jun 30, 2025 | -3.35 Mn |
| Mar 31, 2025 | -1.45 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | -4.33 Mn |
| Jun 30, 2024 | -4.21 Mn |
| Mar 31, 2024 | -4.20 Mn |
| Dec 31, 2023 | -4.69 Mn |
| Sep 30, 2023 | -4.38 Mn |
| Jun 30, 2023 | 5.76 Mn |
| Mar 31, 2023 | -3.72 Mn |
| Dec 31, 2022 | -4.40 Mn |
| Sep 30, 2022 | -4.38 Mn |
| Jun 30, 2022 | -4.29 Mn |
| Mar 31, 2022 | -3.86 Mn |
| Dec 31, 2021 | -3.77 Mn |
| Sep 30, 2021 | 11.10 Mn |
API Access
CollPlant Biotechnologies Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();